Drug Information

Drug General Information
Drug ID
D0R1EO
Former ID
DNC012535
Drug Name
[3-(Biphenyl-4-yloxy)-propyl]-dimethyl-amine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526789]
Formula
C17H21NO
Canonical SMILES
CN(C)CCCOC1=CC=C(C=C1)C2=CC=CC=C2
InChI
1S/C17H21NO/c1-18(2)13-6-14-19-17-11-9-16(10-12-17)15-7-4-3-5-8-15/h3-5,7-12H,6,13-14H2,1-2H3
InChIKey
ITTYRYJIHNHJBL-UHFFFAOYSA-N
PubChem Compound ID
501375
Target and Pathway
Target(s) Lanosterol synthase Target Info Inhibitor [526789]
BioCyc Pathway Cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
Cholesterol biosynthesis III (via desmosterol)
Cholesterol biosynthesis I
Superpathway of cholesterol biosynthesis
Lanosterol biosynthesis
KEGG Pathway Steroid biosynthesis
Metabolic pathways
Biosynthesis of antibiotics
PANTHER Pathway Cholesterol biosynthesis
PathWhiz Pathway Steroid Biosynthesis
Reactome Cholesterol biosynthesis
Activation of gene expression by SREBF (SREBP)
WikiPathways Activation of Gene Expression by SREBP (SREBF)
SREBP signalling
Cholesterol Biosynthesis
Cholesterol biosynthesis
References
Ref 526789J Med Chem. 2003 Sep 25;46(20):4240-3.Oxidosqualene cyclase inhibitors as antimicrobial agents.
Ref 526789J Med Chem. 2003 Sep 25;46(20):4240-3.Oxidosqualene cyclase inhibitors as antimicrobial agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.